CD47 and cancer: While the CD47 signaling cascade remains incompletely understood, recent studies have improved understanding of CD47-dependent signaling and given rise to the development of CD47-targeting anti-cancer therapies that inhibit primary tumor growth and reduce metastasis in various types of cancer.